Jun Li: Clinical Trials

10 trials sponsored by Jun Li, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown. 8 Phase 4, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 8
Phase 22Unknown 2

Follow Jun Li: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gandouling in the Treatment of Wilson's Disease
Gandouling - Wilson's Disease
Phase 4UnknownJun Li2402023-01-012024-02-09
Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction
Wenyang Huoxue Decoction, Wenyang Huoxue placebo - Heart Failure, Myocardial Infarction
Phase 2UnknownJun Li2002021-01-152021-01-06
Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
Modified Wenxin Decoction - Heart Failure, Myocardial Infarction
Phase 2UnknownJun Li2002020-12-152020-12-14
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.
Anti-Platelet Drugs, Lipid Regulating Drugs, Coronary Vasodilator - Unstable Angina
Phase 4UnknownJun Li2402017-08-012017-05-31
Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
Anti-Platelet Drugs, Lipid Regulating Drugs, Coronary Vasodilator - Unstable Angina
Phase 4UnknownJun Li1202017-07-012017-06-07
Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
Anti-Platelet Drugs, Lipid Regulating Drugs, Coronary Vasodilator - Unstable Angina
Phase 4UnknownJun Li1202017-07-012017-06-07
Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.
Anti-Platelet Drugs, Lipid Regulating Drugs, Coronary Vasodilator - Unstable Angina
Phase 4UnknownJun Li1202017-07-012017-06-07
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Shexiang Baoxin pill, SBP placebo, Aspirin Enteric-coated Tablets - Coronary Artery Disease(CAD)
Phase 4UnknownJun Li4402017-06-012017-04-04
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Danlou Tablet, DanLou Tablet placebo, Aspirin Enteric-coated Tablets - Coronary Artery Disease(CAD)
Phase 4UnknownJun Li4402017-06-012017-04-04
One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis
Benzathine Penicillin G - Syphilis
Phase 4UnknownJun Li1502016-08-012018-11-16

Conditions studied

Angina, Unstable (4)  ·  Coronary Artery Disease (2)  ·  Heart Failure (2)  ·  Myocardial Infarction (2)  ·  Hepatolenticular Degeneration (1)  ·  Syphilis (1)

Interventions

Lipid Regulating Agents (4)  ·  Atorvastatin (2)  ·  Clopidogrel (2)  ·  Metoprolol (2)  ·  Tablets (2)  ·  Trimetazidine (2)  ·  Xue-Fu-Zhu-Yu decoction (2)  ·  gualou xiebai banxia decoction (2)  ·  isosorbide-5-mononitrate (2)  ·  Penicillin G (1)  ·  danlou tablet (1)  ·  gluconic acid (1)  ·  shexiang baoxin (1)

Countries

China (2)

Top investigators

Jie Wang, MD (2)

Results publications

PMID 22536282, PMID 23762142, PMID 27777598, PMID 23737852, PMID 25254054, PMID 17090774, PMID 19118718, PMID 20432394, PMID 20531008, PMID 20681275, PMID 21709062, PMID 22019563, PMID 23303884, PMID 27480425, PMID 27847338, PMID 29386200, PMID 9462531, PMID 23173251, PMID 26142341, PMID 27491230, PMID 29444778, PMID 40538652